← SynDRA
TASELISIB
SynDRA canonical compound SYN0037379 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PIK3CA |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
- PIK3CA
- PIK3CG
- PIK3CB
- PIK3CD
Mechanisms of action (all sources)
- PI3K inhibitor
- PIK3CA INHIBITOR
- PIK3CB INHIBITOR
- PIK3CD INHIBITOR
- PIK3CG INHIBITOR
- PIK3CA MODULATOR
Cross-references
Synonyms
- GDC-0032
- RG-7604
- GDC 0032
- UNII-L08J2O299M
- 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide
- CHEMBL2387080
- GDC0032
- L08J2O299M
- Taselisib [INN]
- 2-Methyl-2-(4-{2-[3-Methyl-1-(Propan-2-Yl)-1h-1,2,4-Triazol-5-Yl]-5,6-Dihydroimidazo[1,2-D][1,4]benzoxazepin-9-Yl}-1h-Pyrazol-1-Yl)propanamide
- Taselisib [USAN:INN]
- GTPL7794
- SCHEMBL1485247
- SYN1202
- DTXSID00155842
- BEUQXVWXFDOSAQ-UHFFFAOYSA-N
- Taselisib (GDC0032)
- RG 7604
- TaselisibGDC-0032
- RG7604
- 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO(F)IMIDAZO(1,2-D)(1,4)OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE
- Taselisib (USAN/INN)
- TASELISIB [USAN]
- TASELISIB [WHO-DD]
- Taselisib (GDC-0032)
- HMS3674G19
- AMY39941
- BCP09253
- EX-A1581
- BDBM50434806
- MFCD26142641
- NSC777425
- NSC800985
- s7103
- ZINC68267049
- AKOS026750303
- CCG-269338
- CS-1817
Look up TASELISIB in the interactive SynDRA portal →